NPR's Wendy Schmelzer reports that a study on hormone replacement therapy suggests that women who take estrogen in combination with progestin are at greater risk of developing breast cancer than women who take estrogen alone. The study is released in today's issue of the Journal of the American Medical Association.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.